Cansortium Future Growth

Cansortium's EPS is expected to grow by 137.5% per annum.

n/a

Earnings growth rate

137.5%

EPS growth rate

Pharmaceuticals earnings growth	21.6%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

No updates

Earnings and Revenue Growth Forecasts

DB:2WM - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2024	103	-13	8	15	N/A
3/31/2024	100	-20	11	17	N/A
12/31/2023	97	-23	12	18	N/A
9/30/2023	95	-36	15	21	N/A
6/30/2023	92	-36	12	19	N/A
3/31/2023	90	-34	13	20	N/A
12/31/2022	88	-37	12	19	N/A
9/30/2022	83	-15	22	34	N/A
6/30/2022	76	-2	7	24	N/A
3/31/2022	70	-24	-21	0	N/A
12/31/2021	65	-19	-26	-5	N/A
9/30/2021	62	-31	-38	-20	N/A
6/30/2021	61	-47	-26	-15	N/A
3/31/2021	57	-28	-1	5	N/A
12/31/2020	52	-37	1	7	N/A
9/30/2020	47	-48	12	17	N/A
6/30/2020	40	-51	-5	2	N/A
3/31/2020	33	-51	-21	-8	N/A
12/31/2019	29	-53	-37	-23	N/A
9/30/2019	24	-54	-58	-42	N/A
6/30/2019	19	-13	-46	-29	N/A
3/31/2019	14	-9	-35	-23	N/A
12/31/2018	8	0	-22	-12	N/A
9/30/2018	3	16	-16	-7	N/A
6/30/2018	0	-15	-13	-8	N/A
3/31/2018	0	-16	N/A	-7	N/A
12/31/2017	N/A	-10	N/A	-5	N/A

Earnings vs Savings Rate: Insufficient data to determine if 2WM's forecast earnings growth is above the savings rate (1%).

Earnings vs Market: Insufficient data to determine if 2WM's earnings are forecast to grow faster than the German market

High Growth Earnings: Insufficient data to determine if 2WM's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 2WM's revenue is forecast to grow faster than the German market.

High Growth Revenue: Insufficient data to determine if 2WM's revenue is forecast to grow faster than 20% per year.

Future ROE: Insufficient data to determine if 2WM's Return on Equity is forecast to be high in 3 years time